Completed PHASE1 INTERVENTIONAL 1-arm NCT04193319

Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects

Study on the Pharmacokinetics of Fluconazole on Single-center, One-arm, Open and Fixed Sequences of Fluzoparib in Healthy Male Subjects

Sponsor: Hunan Cancer Hospital

Conditions Advanced Cancer

Interventions Fluconazole Fluzoparib

Updated 4 times since 2020 Last updated: Dec 8, 2019 Started: Jul 19, 2019 Primary completion: Sep 12, 2019 Completion: Sep 12, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Advanced Cancer and is currently completed. Hunan Cancer Hospital leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2020 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hunan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Data source: Jiangsu HengRui Medicine Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hunan, China